Anti-miR-203 suppresses ER-positive breast cancer growth and stemness by targeting SOCS3

Naoshad Muhammad(Saint Louis University), Ratna B. Ray(Saint Louis University)
Oncotarget
August 10, 2016
Cited by 187


Related Papers